Alexandre Dentel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexandre Dentel has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Alejandra Daruich
3 shared publications- Serge Picaud
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France
3 shared publications Catherine Vignal-Clermont
Ophthalmology Department, Rothschild Foundation Hospital, Paris, France (A.D., E.B., T.C., F.M., P.D., C.V.-C., G.C., G.C.M.).
2 shared publications- Clémence Bradic
Institut de la Vision, INSERM, CNRS, Sorbonne Université
2 shared publications Dominique Brémond-Gignac
2 shared publicationsE. Koch
Service d'ophtalmologie, centre hospitalier de Versailles, 1, rue Richaud, 78000 Versailles, France; Inserm, centre d'investigation clinique 1423, centre hospitalier national des Quinze-Vingts, université Pierre-et-Marie-Curie - Paris 6, 75012 Paris, France
2 shared publications
Latest Publications
- 1 October 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (10) , 1733-1739
PIGMENT EPITHELIUM DETACHMENT IN SEVERE ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY
Purpose: To describe the spectrum of optical coherence tomography (OCT) findings in acute posterior multifocal placoid pigment epitheliopathy (APMPPE), with a specific focus on the prevalence of pigment epithelium detachments (PEDs). Methods: Multicenter, retrospective, longitudinal study including patients diagnosed with APMPPE based on color fundus photography, OCT, and fluorescein angiography. Demographics, visual acuity, and the following OCT findings were assessed: outer retinal hyperreflectivity, serous retinal detachment (SRD), bacillary layer detachment (BALAD), and PED. Results: Forty-six eyes of 27 patients were included. The median age at presentation was 23 years (range: 18–36 years), and 17 patients (62.9%) were men. At baseline, outer retinal hyperreflectivity was found in all eyes, while BALAD, SRD, and PED were observed in 22 (47.8%), 14 (30.4%), and 26 eyes (56.5%), respectively. A univariate logistic regression showed a significant association between the presence of PED and a worse baseline visual acuity (odds ratio [OR]: 5.3; 95% confidence interval [CI]: 1.5–18.6; P = 0.01), the presence of BALAD (OR: 9.0; 95% CI: 2.3–35.6; P = 0.002), and the presence of SRD (OR: 7.3; 95% CI: 1.4–38.3; P = 0.02). Conclusion: PEDs were significantly associated with a poorer initial visual acuity, as well as with the presence of BALAD and SRD on presentation. These findings suggest that PEDs could be used as a biomarker of disease severity and choriocapillaris ischemia in APMPPE.
- 1 October 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (10) , 1733-1739
PIGMENT EPITHELIUM DETACHMENT IN SEVERE ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY
Purpose: To describe the spectrum of optical coherence tomography (OCT) findings in acute posterior multifocal placoid pigment epitheliopathy (APMPPE), with a specific focus on the prevalence of pigment epithelium detachments (PEDs). Methods: Multicenter, retrospective, longitudinal study including patients diagnosed with APMPPE based on color fundus photography, OCT, and fluorescein angiography. Demographics, visual acuity, and the following OCT findings were assessed: outer retinal hyperreflectivity, serous retinal detachment (SRD), bacillary layer detachment (BALAD), and PED. Results: Forty-six eyes of 27 patients were included. The median age at presentation was 23 years (range: 18–36 years), and 17 patients (62.9%) were men. At baseline, outer retinal hyperreflectivity was found in all eyes, while BALAD, SRD, and PED were observed in 22 (47.8%), 14 (30.4%), and 26 eyes (56.5%), respectively. A univariate logistic regression showed a significant association between the presence of PED and a worse baseline visual acuity (odds ratio [OR]: 5.3; 95% confidence interval [CI]: 1.5–18.6; P = 0.01), the presence of BALAD (OR: 9.0; 95% CI: 2.3–35.6; P = 0.002), and the presence of SRD (OR: 7.3; 95% CI: 1.4–38.3; P = 0.02). Conclusion: PEDs were significantly associated with a poorer initial visual acuity, as well as with the presence of BALAD and SRD on presentation. These findings suggest that PEDs could be used as a biomarker of disease severity and choriocapillaris ischemia in APMPPE.
- 8 March 2025
- Published by MyJove Corporation
- No. 217,p. e67483
JoVE Video Dataset
Subretinal injection, the delivery of a solution between the photoreceptors and the retinal pigment epithelium (RPE), creates a subretinal space where components are in direct contact with photoreceptors and RPE cells. This delivery method allows for targeted treatment of these cells. Therapeutics for subretinal injection have been developed and approved, particularly for inherited retinal diseases. In animals, subretinal injection procedures can be challenging due to the lens size, especially in rodents. This article describes methods for subretinal injection in rats, enabling intraoperative visualization and control of both the injection site and the size of the detached area, as performed in humans. The procedure is conducted under general and local anesthesia and requires pupil dilation. Using an ophthalmic microscope, the subretinal injection is performed through a 30 G scleral channel, with the cannula tip gently applied to the retina to create a retinotomy. Volumes ranging from 10-25 µL can be delivered, corresponding to two-fifths to half of the rat retina. Immediate postoperative examinations using fundus photography and optical coherence tomography confirm successful delivery into the subretinal space with visible subretinal fluid. The major risks of this procedure include lens damage (cataract), detachment failure, intravitreal hemorrhage, subretinal hemorrhage, and postoperative keratitis. In addition to delivering therapeutics into the subretinal space, this technique is used to induce short-term or long-term retinal detachment using aqueous or viscous products, respectively. Unlike the transscleral approach, this method enables precise intraoperative positioning of the retinal detachment.
- 8 March 2025
- Published by MyJove Corporation
- No. 217,p. e67483
JoVE Video Dataset
Subretinal injection, the delivery of a solution between the photoreceptors and the retinal pigment epithelium (RPE), creates a subretinal space where components are in direct contact with photoreceptors and RPE cells. This delivery method allows for targeted treatment of these cells. Therapeutics for subretinal injection have been developed and approved, particularly for inherited retinal diseases. In animals, subretinal injection procedures can be challenging due to the lens size, especially in rodents. This article describes methods for subretinal injection in rats, enabling intraoperative visualization and control of both the injection site and the size of the detached area, as performed in humans. The procedure is conducted under general and local anesthesia and requires pupil dilation. Using an ophthalmic microscope, the subretinal injection is performed through a 30 G scleral channel, with the cannula tip gently applied to the retina to create a retinotomy. Volumes ranging from 10-25 µL can be delivered, corresponding to two-fifths to half of the rat retina. Immediate postoperative examinations using fundus photography and optical coherence tomography confirm successful delivery into the subretinal space with visible subretinal fluid. The major risks of this procedure include lens damage (cataract), detachment failure, intravitreal hemorrhage, subretinal hemorrhage, and postoperative keratitis. In addition to delivering therapeutics into the subretinal space, this technique is used to induce short-term or long-term retinal detachment using aqueous or viscous products, respectively. Unlike the transscleral approach, this method enables precise intraoperative positioning of the retinal detachment.
- 7 March 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 217,p. e67483
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
Subretinal injection, the delivery of a solution between the photoreceptors and the retinal pigment epithelium (RPE), creates a subretinal space where components are in direct contact with photoreceptors and RPE cells. This delivery method allows for targeted treatment of these cells. Therapeutics for subretinal injection have been developed and approved, particularly for inherited retinal diseases. In animals, subretinal injection procedures can be challenging due to the lens size, especially in rodents. This article describes methods for subretinal injection in rats, enabling intraoperative visualization and control of both the injection site and the size of the detached area, as performed in humans. The procedure is conducted under general and local anesthesia and requires pupil dilation. Using an ophthalmic microscope, the subretinal injection is performed through a 30 G scleral channel, with the cannula tip gently applied to the retina to create a retinotomy. Volumes ranging from 10-25 µL can be delivered, corresponding to two-fifths to half of the rat retina. Immediate postoperative examinations using fundus photography and optical coherence tomography confirm successful delivery into the subretinal space with visible subretinal fluid. The major risks of this procedure include lens damage (cataract), detachment failure, intravitreal hemorrhage, subretinal hemorrhage, and postoperative keratitis. In addition to delivering therapeutics into the subretinal space, this technique is used to induce short-term or long-term retinal detachment using aqueous or viscous products, respectively. Unlike the transscleral approach, this method enables precise intraoperative positioning of the retinal detachment.
- 7 March 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 217,p. e67483
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
Subretinal injection, the delivery of a solution between the photoreceptors and the retinal pigment epithelium (RPE), creates a subretinal space where components are in direct contact with photoreceptors and RPE cells. This delivery method allows for targeted treatment of these cells. Therapeutics for subretinal injection have been developed and approved, particularly for inherited retinal diseases. In animals, subretinal injection procedures can be challenging due to the lens size, especially in rodents. This article describes methods for subretinal injection in rats, enabling intraoperative visualization and control of both the injection site and the size of the detached area, as performed in humans. The procedure is conducted under general and local anesthesia and requires pupil dilation. Using an ophthalmic microscope, the subretinal injection is performed through a 30 G scleral channel, with the cannula tip gently applied to the retina to create a retinotomy. Volumes ranging from 10-25 µL can be delivered, corresponding to two-fifths to half of the rat retina. Immediate postoperative examinations using fundus photography and optical coherence tomography confirm successful delivery into the subretinal space with visible subretinal fluid. The major risks of this procedure include lens damage (cataract), detachment failure, intravitreal hemorrhage, subretinal hemorrhage, and postoperative keratitis. In addition to delivering therapeutics into the subretinal space, this technique is used to induce short-term or long-term retinal detachment using aqueous or viscous products, respectively. Unlike the transscleral approach, this method enables precise intraoperative positioning of the retinal detachment.
- 17 February 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 265, 73-79
Incidence and Outcomes of Eye Trauma Associated With Recreative Use of Nonpowder Toy Guns: A 12-Year Retrospective Study
- 17 February 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 265, 73-79
Incidence and Outcomes of Eye Trauma Associated With Recreative Use of Nonpowder Toy Guns: A 12-Year Retrospective Study
- 16 January 2024
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (4) , 540-544
Optic Disc Hypoplasia Assessment in PAX6-Related Aniridia
Background: This study aims to characterize optic disc hypoplasia in congenital aniridia using ultra-wide-field imaging (UWFI) and nonmydriatic retinal photography (NMRP). We also investigated the relation between optic disc hypoplasia and foveal hypoplasia. Methods: This is a retrospective case series of patients diagnosed with PAX6-related aniridia in a National Referral Center, who underwent UWFI, NMRP, and spectral-domain optical coherence tomography (SD-OCT). The disc diameter (DD) and the disc-to-fovea distance (DF) were measured. The DD:DF ratio was used to assess the relative size of the optic disc. The analyses were carried with respect to paired age- and sex-matched healthy controls. SD-OCT was used for foveal hypoplasia grading (from 1 to 4) and retinal nerve fiber layer (RNFL) analysis. Results: Mean manual DD:DF ratio was 0.33 (95% CI: 0.31–0.35) in aniridia patients versus 0.37 (95% CI: 0.36–0.39) in control patients (n = 20, P = 0.005) measured on NMRP and 0.32 (95% CI: 0.30–0.35) in aniridia patients versus 0.37 (95% CI: 0.37–0.39) in control patients (n = 26, P < 0.0001) when assessed on UWFI. Mean semiautomated DD:DF ratio measured on UWFI in aniridia patients was 0.31 (95% CI: 0.29–0.33) versus 0.37 (95% CI: 0.36–0.38) in control patients (P < 0.0001). Also, a negative correlation was found significant between the grade of foveal hypoplasia and the mean semiautomated DD:DF ratio (r = −0.52, 95% CI: −0.76 to −0.15, P = 0.0067). Finally, a significant negative correlation was found between the peripapillary temporal RNFL thickness and the grade of foveal hypoplasia (P = 0.0034). Conclusions: The DD:DF ratio is significantly reduced in PAX6-related aniridia patients and correlates with the severity of foveal hypoplasia. This ratio is a valuable tool for optic disc hypoplasia assessment in congenital aniridia, especially when provided semiautomatically by UWFI.
- 16 January 2024
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (4) , 540-544
Optic Disc Hypoplasia Assessment in PAX6-Related Aniridia
Background: This study aims to characterize optic disc hypoplasia in congenital aniridia using ultra-wide-field imaging (UWFI) and nonmydriatic retinal photography (NMRP). We also investigated the relation between optic disc hypoplasia and foveal hypoplasia. Methods: This is a retrospective case series of patients diagnosed with PAX6-related aniridia in a National Referral Center, who underwent UWFI, NMRP, and spectral-domain optical coherence tomography (SD-OCT). The disc diameter (DD) and the disc-to-fovea distance (DF) were measured. The DD:DF ratio was used to assess the relative size of the optic disc. The analyses were carried with respect to paired age- and sex-matched healthy controls. SD-OCT was used for foveal hypoplasia grading (from 1 to 4) and retinal nerve fiber layer (RNFL) analysis. Results: Mean manual DD:DF ratio was 0.33 (95% CI: 0.31–0.35) in aniridia patients versus 0.37 (95% CI: 0.36–0.39) in control patients (n = 20, P = 0.005) measured on NMRP and 0.32 (95% CI: 0.30–0.35) in aniridia patients versus 0.37 (95% CI: 0.37–0.39) in control patients (n = 26, P < 0.0001) when assessed on UWFI. Mean semiautomated DD:DF ratio measured on UWFI in aniridia patients was 0.31 (95% CI: 0.29–0.33) versus 0.37 (95% CI: 0.36–0.38) in control patients (P < 0.0001). Also, a negative correlation was found significant between the grade of foveal hypoplasia and the mean semiautomated DD:DF ratio (r = −0.52, 95% CI: −0.76 to −0.15, P = 0.0067). Finally, a significant negative correlation was found between the peripapillary temporal RNFL thickness and the grade of foveal hypoplasia (P = 0.0034). Conclusions: The DD:DF ratio is significantly reduced in PAX6-related aniridia patients and correlates with the severity of foveal hypoplasia. This ratio is a valuable tool for optic disc hypoplasia assessment in congenital aniridia, especially when provided semiautomatically by UWFI.
- Open Access
- 4 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (31) , eadg8163
Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies
The anatomical differences between the retinas of humans and most animal models pose a challenge for testing novel therapies. Nonhuman primate (NHP) retina is anatomically closest to the human retina. However, there is a lack of relevant NHP models of retinal degeneration (RD) suitable for preclinical studies. To address this unmet need, we generated three distinct inducible cynomolgus macaque models of RD. We developed two genetically targeted strategies using optogenetics and CRISPR-Cas9 to ablate rods and mimic rod-cone dystrophy. In addition, we created an acute model by physical separation of the photoreceptors and retinal pigment epithelium using a polymer patch. Among the three models, the CRISPR-Cas9–based approach was the most advantageous model in view of recapitulating disease-specific features and its ease of implementation. The acute model, however, resulted in the fastest degeneration, making it the most relevant model for testing end-stage vision restoration therapies such as stem cell transplantation.
- 4 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (31) , eadg8163
Open AccessInducible nonhuman primate models of retinal degeneration for testing end-stage therapies
The anatomical differences between the retinas of humans and most animal models pose a challenge for testing novel therapies. Nonhuman primate (NHP) retina is anatomically closest to the human retina. However, there is a lack of relevant NHP models of retinal degeneration (RD) suitable for preclinical studies. To address this unmet need, we generated three distinct inducible cynomolgus macaque models of RD. We developed two genetically targeted strategies using optogenetics and CRISPR-Cas9 to ablate rods and mimic rod-cone dystrophy. In addition, we created an acute model by physical separation of the photoreceptors and retinal pigment epithelium using a polymer patch. Among the three models, the CRISPR-Cas9–based approach was the most advantageous model in view of recapitulating disease-specific features and its ease of implementation. The acute model, however, resulted in the fastest degeneration, making it the most relevant model for testing end-stage vision restoration therapies such as stem cell transplantation.
- 3 August 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (12) , 1122
Sight Threat, Life Threat
- 3 August 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (12) , 1122
Sight Threat, Life Threat
- 12 June 2023
- Published by Elsevier in Archives de Pédiatrie
- Vol. 30 (6) , 396-400
Specificities of pediatric ocular emergencies before and during the COVID-19 era: A retrospective comparative study in an eye-related emergency department in Paris
- 12 June 2023
- Published by Elsevier in Archives de Pédiatrie
- Vol. 30 (6) , 396-400
Specificities of pediatric ocular emergencies before and during the COVID-19 era: A retrospective comparative study in an eye-related emergency department in Paris
- 1 May 2023
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 141 (5) , e230083
Intravitreal Glioma in a Boy Aged 7 Years
This case report discusses a diagnosis of intravitreal glioma in a boy aged 7 years with neurofibromatosis type 1.
- 1 May 2023
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 141 (5) , e230083
Intravitreal Glioma in a Boy Aged 7 Years
This case report discusses a diagnosis of intravitreal glioma in a boy aged 7 years with neurofibromatosis type 1.
- Open Access
- 20 April 2023
- Published by Elsevier in Ophthalmology Science
- Vol. 3 (4) , 100316
Adaptive Optics Flood Illumination Ophthalmoscopy in Nonhuman Primates
- 20 April 2023
- Published by Elsevier in Ophthalmology Science
- Vol. 3 (4) , 100316
Open AccessAdaptive Optics Flood Illumination Ophthalmoscopy in Nonhuman Primates